In vitro Activities of the Benzoquinolizine Fluoroquinolone Levonadifloxacin (WCK 771) and Other Antimicrobial Agents Against Human Mycoplasmas and Ureaplasmas Including Isolates with Defined Resistance Mechanisms
release_6umlvrlakzhohmoj2tttbhuxpi
by
G. Xue, D.M. Crabb, L. Xiao, Y. Liu, K.B. Waites
2018 AAC.01348-18
Abstract
Levonadifloxacin (WCK 771) was evaluated against 68 type strains and clinical isolates of <jats:italic>Mycoplasma genitalium</jats:italic>, <jats:italic>Mycoplasma hominis</jats:italic>, <jats:italic>Mycoplasma pneumoniae</jats:italic> and <jats:italic>Ureaplasma</jats:italic> species in comparison to moxifloxacin, levofloxacin, tetracycline and azithromycin or clindamycin. Levonadifloxacin MICs were ≤ 0.5 μg/ml for <jats:italic>Mycoplasma genitalium.</jats:italic> MIC<jats:sub>90s</jats:sub> (μg/ml) were 1 (<jats:italic>Mycoplasma hominis</jats:italic>), 0.125 (<jats:italic>Mycoplasma pneumoniae</jats:italic>) and 2 (<jats:italic>Ureaplasma</jats:italic> spp). Levonadifloxacin merits further study for treating infections caused by these organisms.
In application/xml+jats
format
Archived Files and Locations
application/pdf 157.9 kB
file_pwbkh7ztazhkvdvjzq4v2be66y
|
aac.asm.org (web) web.archive.org (webarchive) |
access all versions, variants, and formats of this works (eg, pre-prints)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar